Eli Lilly & Co. (NYSE:LLY)

Short Sellers Back Way Off Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

The bull market is now closer to nine years old than it is eight, and the great stock market rally of 2017 has continued to amaze skeptics and bulls alike. ...
Read Full Story »

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Third-quarter earnings reporting season is now well under way. So far, things are looking good. The health care sector has yet to see any significant earnings representation, but that will ...
Read Full Story »

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

With a market that has become as expensive as this one, there is one key driver that can keep things going, and that’s positive earnings or guidance for the next ...
Read Full Story »

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

It is not unusual for big biotech and pharmaceutical companies to sign research and development pacts with smaller companies and smaller entities. These pacts often come with big price tags ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

Stocks were indicated to open higher on Tuesday morning after a very dull Columbus Day-induced weak volume and low volatility Monday. The S&P 500 and Dow Jones Industrial Average are ...
Read Full Story »

Major Pharma Short Interest Piles On

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech company, it would be in a successful treatment of Alzheimer's ...
Read Full Story »

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Stocks were looking for direction on Friday morning, after the Dow and S&P 500 broke to new all-time highs this week. The Dow now has hit close to 50 new highs since ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

You know it is a different world when big pharmaceutical giants began to lay off workers in recent years. Now it is Eli Lilly and Co. (NYSE: LLY) joining in ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »